Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
  • Address and mission.
  • Equipment/Knowhow.
  • Staff.
  • Projects.
  • Publications.
  • Advised theses.
  • Project partners.
  • Sponsors.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Department of Internal Medicine

Division of Oncology

Project management at chosen institution:

A novel cytokine based therapeutic strategy for treating acute myeloid leukemia
• Project type: EN: Forschungsförderung.
• Project Leader: Dutta Sayantanee
• MUG Research Units: Division of Oncology ;
• Funded by: Österreichische Krebshilfe Steiermark, Rudolf-Hans-Bartsch-Straße 15-17, 8042 Graz, Austria
• Duration: 01.04.2025-31.03.2027
   .

Boosting immunotherapy in non-small cell lung cancer
• Project type: EN: Forschungsförderung.
• Project Leader: Jäger Vanessa
• MUG Research Units: Division of Oncology ;
• Funded by: Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie, AKH-Wien, Klinik für Innere Medizin I Währinger Gürtel 18-20, 1090 Wien, Austria
• Duration: 01.08.2024-31.12.2026
   .

Characterizing the epigenetics of lung cancer progression to inform personalized treatment
• Project type: EN: Forschungsförderung.
• Project Leader: Vosberg Sebastian
• MUG Research Units: Division of Oncology ;
• Funded by: MEFOgraz , Neue Stiftingtalstraße 6 WEST, 8010 Graz, Austria
• Duration: 01.02.2022-31.12.2026
   .

Deciphering the role of necroptosis-induced inflammation in lung adenocarcinomas
• Project type: EN: Forschungsförderung.
• Project Leader: Jost Philipp
• MUG Research Units: Division of Oncology ;
• Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
• Duration: 01.01.2024-22.12.2027
   .

Hypermethylation as a mechanism for cisplatin resistance in germ cell tumors
• Project type: EN: Forschungsförderung.
• Project Leader: Terbuch Angelika
• MUG Research Units: Division of Oncology ;
• Funded by: Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie, AKH-Wien, Klinik für Innere Medizin I Währinger Gürtel 18-20, 1090 Wien, Austria
• Duration: 01.01.2023-31.12.2025
   .

Identifying novel lung cancer drivers: Unravelling the functional role of genes affected by large copy number gains
• Project type: EN: Forschungsförderung.
• Project Leader: Dengler Michael
• MUG Research Units: Division of Oncology ;
• Funded by: Verein für Krebskranke an der Medizinischen Universität Graz, Auenbruggerplatz 15, 8036 Graz, Austria
• Duration: 01.10.2024-31.12.2026
   .

Identifying novel targets to combat aberrant TP53 mediated therapeutic resistance in acute myeloid leukemia using CRISPRko screens
• Project type: EN: Forschungsförderung.
• Project Leader: Dutta Sayantanee
• MUG Research Units: Division of Oncology ;
• Funded by: Gilead Sciences, 2 Roundwood Avenue , South Building, Stockley Park, Uxbridge, UB11 1AF Middlesex, United Kingdom
• Duration: 01.02.2024-31.07.2026
   .

In silico characterization of 1q21 amplification in advanced lung adenocarcinoma
• Project type: EN: Forschungsförderung.
• Project Leader: Vizar Cisarova Katarina
• MUG Research Units: Division of Oncology ;
• Funded by: MEFOgraz , Neue Stiftingtalstraße 6 WEST, 8010 Graz, Austria
• Duration: 01.02.2025-31.01.2026
   .

In vivo competition of AML cells harboring different TP53 aberrations
• Project type: EN: Forschungsförderung.
• Project Leader: Dutta Sayantanee
• MUG Research Units: Division of Oncology ;
• Funded by: Leukämiehilfe Steiermark, Kainbach bei Graz, Austria
• Duration: 01.06.2025-01.06.2026
   .

Innovative approaches to strengthen immunotherapy in lung cancer
• Project type: EN: Forschungsförderung.
• Project Leader: Jäger Vanessa
• MUG Research Units: Division of Oncology ;
• Funded by: Österreichische Krebshilfe Steiermark, Rudolf-Hans-Bartsch-Straße 15-17, 8042 Graz, Austria
• Duration: 01.04.2025-31.03.2027
   .

Integration of Early Palliative Care into Oncology
• Project type: EN: Forschungsförderung.
• Project Leader: Huemer Matthias
• MUG Research Units: Division of Oncology ;
• Funded by: Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie, AKH-Wien, Klinik für Innere Medizin I Währinger Gürtel 18-20, 1090 Wien, Austria
• Duration: 01.07.2021-31.12.2025
   .

INTERACT-EUROPE 100
• Project type: EN: Forschungsförderung.
• Project Leader: Jost Philipp
• MUG Research Units: Division of Oncology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Duration: 01.12.2023-30.11.2026
   .

Spatial transcriptomics to predict treatment response and personalize therapy in HER2+ Breast Cancer
• Project type: EN: Forschungsförderung.
• Project Leader: Vizar Cisarova Katarina
• MUG Research Units: Division of Oncology ;
• Funded by: Land Steiermark, Graz, Austria
• Duration: 01.05.2025-15.10.2025
   .

TARgetinG disease pErsisTence and progression of MyeloProliferative Neoplasms
• Project type: EN: Forschungsförderung.
• Project Leader: Jost Philipp
• MUG Research Units: Division of Oncology ;
• Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
• Duration: 01.06.2024-10.07.2028
   .

Tumor biological and immunological characterization of localized therapy-refractory triple-negative breast carcinomas
• Project type: EN: Forschungsförderung.
• Project Leader: Rinnerthaler Gabriel
• MUG Research Units: Division of Oncology ;
• Funded by: Österreichische Krebshilfe Steiermark, Rudolf-Hans-Bartsch-Straße 15-17, 8042 Graz, Austria
• Duration: 01.04.2025-31.03.2027
   .

TWINNING FOR EXCELLENCE TO ADVANCE RESEARCH IN THE ACTIVATION OF ANTI-TUMOR IMMUNE RESPONSE AFTER ELECTROCHEMOTHERAPY COMBINED WITH GENE ELETROTRANSFER OF pDNA ENCODING ICIs
• Project type: EN: Forschungsförderung.
• Project Leader: Jost Philipp
• MUG Research Units: Division of Oncology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Duration: 01.10.2024-30.09.2027
   .

Project management at other institution:

CRISPR/Cas9-Based Genome Engineering to mimic Clonal Hematopoiesis and Myeloid Neoplasia in Human Hematopoietic Stem and Progenitor Cells
• Project type: EN: Forschungsförderung.
• Project Leader: Reinisch Andreas
• MUG Research Units: Division of Haematology ;
• Funded by: MEFOgraz , Neue Stiftingtalstraße 6 WEST, 8010 Graz, Austria
• Duration: 01.02.2018-31.12.2025
   .

tAckLing menTal Health cancer patients and their families: digital solutions for bEtter cAre
• Project type: EN: Forschungsförderung.
• Project Leader: Andritsch Elisabeth
• MUG Research Units: Division of Medical Psychology, Psychosomatics and Psychotherapeutic Medicine ; Division of Oncology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Duration: 01.09.2024-31.08.2027
   .

↑ Top of page / Navigation

© Med Uni Graz • Imprint